Anxiety is one of the most common mental health concerns in modern adults, and one of the most undertreated. Conventional anxiolytics (benzodiazepines, SSRIs) are effective for many patients but carry significant limitations: benzodiazepines produce dependence and cognitive impairment; SSRIs require weeks to take effect and cause sexual side effects in a substantial proportion of patients.
Selank occupies a different pharmacological space entirely: an anxiolytic peptide that reduces anxiety through modulation of natural neurotransmitter systems, without sedation, cognitive blunting, or dependence.
What Is Selank?
Selank is a synthetic analogue of tuftsin, a naturally occurring tetrapeptide that is a fragment of immunoglobulin G (IgG). It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and has been used clinically in Russia for generalised anxiety disorder, neurasthenia, and cognitive performance enhancement since the 1990s.
The key pharmacological properties that distinguish Selank from conventional anxiolytics:
- GABAergic modulation: Selank enhances GABA-A receptor function (the same target as benzodiazepines) but through allosteric modulation rather than direct agonism, producing anxiolytic effects without the sedation, cognitive impairment, and dependence associated with full GABA agonists.
- Serotonin metabolism: Selank upregulates tryptophan hydroxylase and increases serotonin turnover, contributing to mood stabilisation.
- BDNF upregulation: Like Semax, Selank increases BDNF expression, which is relevant for both anxiety management and cognitive function.
- Anti-inflammatory effects: Selank modulates cytokine production and reduces neuroinflammation, addressing the inflammatory component of anxiety disorders.
Clinical Applications
Generalised Anxiety Disorder (GAD)
Selank's most studied indication. Clinical trials in Russia have shown comparable anxiolytic efficacy to low-dose benzodiazepines for GAD, with a significantly superior side effect profile: no sedation, no cognitive impairment, no withdrawal, and no development of tolerance with continued use.
Cognitive Performance Under Stress
Anxiety impairs working memory, attention, and executive function through multiple mechanisms (cortisol-mediated hippocampal suppression, attentional narrowing, disrupted sleep). Selank's anxiety reduction translates directly into improved cognitive performance, particularly in patients whose cognitive difficulties are substantially anxiety-driven.
Stress Resilience
Beyond treating established anxiety, Selank is used prophylactically in high-pressure environments (performance, exams, demanding work periods) to maintain cognitive function and emotional stability under stress.
Nootropic Stack Complement
Selank is frequently used alongside Semax in cognitive enhancement stacks: Selank provides the anxiolytic and mood-stabilising component while Semax provides the BDNF-driven focus and working memory enhancement. Together, they address the cognitive and emotional dimensions of brain performance.
Administration
Selank is available in intranasal (nasal drop) and subcutaneous injectable forms. The intranasal route is preferred for cognitive applications because it provides direct delivery to the central nervous system through the olfactory route, with faster onset of effect.
- Intranasal: 2 to 3 drops per nostril (250 mcg total), once to twice daily
- Subcutaneous: Less commonly used; dosing varies by protocol
The intranasal form is preferred for acute anxiety or cognitive performance applications due to its rapid onset (effects typically within 30 to 60 minutes).
Side Effects and Safety Profile
Selank has an excellent safety profile supported by decades of Russian clinical use:
- No withdrawal symptoms or dependence even after prolonged use
- No sedation at standard doses
- No sexual side effects (common with SSRIs)
- No cognitive impairment (which contrasts sharply with benzodiazepines)
- Mild injection site reactions with subcutaneous administration
Selank should be used with physician guidance in patients already on medications that affect GABAergic or serotonergic neurotransmission, including antidepressants, anxiolytics, and antipsychotics.
The Broader Context: Anxiety and Hormonal Health
Anxiety in adults, particularly men over 35, is frequently compounded by hormonal factors:
- Cortisol excess: Chronic stress drives cortisol elevation, which depletes serotonin, disrupts GABA function, and shrinks hippocampal volume
- Testosterone deficiency: Low testosterone is directly associated with anxiety, irritability, and reduced stress resilience in men
- Thyroid dysregulation: Subclinical hyperthyroidism commonly presents as anxiety
A comprehensive approach to anxiety through Longegra includes assessment of these underlying hormonal drivers alongside Selank or other peptide-based interventions.
Frequently Asked Questions (FAQs)
No. Selank does not produce dependence, tolerance, or withdrawal symptoms, which is a fundamental pharmacological distinction from benzodiazepines. This makes it suitable for ongoing use without the escalating dose requirements or discontinuation difficulties associated with conventional anxiolytics.
